Marker Therapeutics, Inc. (MRKR) financial statements (2021 and earlier)

Company profile

Business Address 3200 SOUTHWEST FREEWAY
HOUSTON, TX 77027
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments446258700
Cash and cash equivalents446258700
Receivables 0     
Prepaid expense2000 0 
Other undisclosed current assets0   0  
Total current assets:456258700
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment00     
Prepaid expense    0  
Deferred costs      0
Prepaid expense and other noncurrent assets0
Total noncurrent assets:10  0 0
TOTAL ASSETS:466258700
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2321 1 
Accounts payable1211 1 
Accrued liabilities0000 0 
Employee-related liabilities0000   
Other undisclosed accounts payable and accrued liabilities0000 0 
Debt0 000 3
Derivative instruments and hedges, liabilities000026 0
Due to related parties      0
Other liabilities   00 0
Other undisclosed current liabilities    115
Total current liabilities:23222819
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt     2 
Accounts payable and accrued liabilities     2 
Total noncurrent liabilities:0    2 
Total liabilities:23222849
Stockholders' equity
Stockholders' equity attributable to parent, including:445946(21)(1)(9)
Common stock0000000
Additional paid in capital3723651611521128546
Accumulated other comprehensive loss      (0)
Accumulated deficit(328)(306)(157)(146)(134)(86) 
Other undisclosed stockholders' equity attributable to parent      (55)
Total stockholders' equity:445946(21)(1)(9)
Other undisclosed liabilities and equity     (2) 
TOTAL LIABILITIES AND EQUITY:466258700

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues0000   
Revenue, net0    
Other income   0 
Cost of revenue
(Cost of Goods and Services Sold)
     (0)(0)
Gross profit:0000 (0)(0)
Operating expenses(23)(148)(12)(8)(6)(4)(1)
Other undisclosed operating income (loss)  (0)(0) 0 
Operating loss:(23)(148)(12)(8)(6)(3)(2)
Nonoperating income (expense)10  (9)(0)2
Investment income, nonoperating10  (9)02
Foreign currency transaction gain (loss), before tax    0(0)0
Interest and debt expense  0(0)(0)(27) 
Income (loss) from continuing operations before income taxes:(21)(148)(11)(9)(15)(30)0
Income tax benefit     1 
Income (loss) before gain (loss) on sale of properties:(21)(148)(11)(9)(15)(29)0
Other undisclosed net income (loss)0   (19)(2) 
Net income (loss):(21)(148)(11)(9)(34)(31)0
Other undisclosed net income (loss) attributable to parent (0)06   
Net income (loss) available to common stockholders, basic:(21)(148)(11)(2)(34)(31)0
Dilutive securities, effect on basic earnings per share   (3)   
Net income (loss) available to common stockholders, diluted:(21)(148)(11)(5)(34)(31)0

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(21)(148)(11)(9)(34)(31)0
Other comprehensive loss    (34)  
Comprehensive income (loss):(21)(148)(11)(9)(68)(31)0
Other undisclosed comprehensive income, net of tax, attributable to parent     0 
Comprehensive income (loss), net of tax, attributable to parent:(21)(148)(11)(9)(68)(31)0

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: